The assistant professor of neurology at the University of Virginia spoke at the 2022 American Epilepsy Society Annual Meeting about clinical outcomes of patients with dementia who experience seizures.
This video originally appeared on NeurologyLive. The summary below has been lightly edited.
Recent research has proven a strong association between seizures and dementia, as findings have shown the high impact seizures have on clinical and mortality outcomes. As patients with epilepsy experience symptoms of cognitive decline, patients with dementia are similarly at a high risk of developing seizures. In addition, seizures have been often associated with more severe cognitive impairment among patients with dementia.
Recently, Ifrah Zawar, MD, presented an abstract on the clinical outcomes of patients who experience both seizures and dementia during a poster session at the 2022 American Epilepsy Society Annual Meeting, held December 2-6, in Nashville, Tennessee. In her presentation, she provided an overview of the study, in which results demonstrated that patients with active seizures and dementia at a younger age have worse cognition, poorer function, and higher mortality rates compared with patients who have dementia without seizures.
At the meeting, Zawar, assistant professor of neurology at the University of Virginia, sat down with NeurologyLive® for an interview and offered a summary about the current knowns and unknowns about epilepsy and seizures in those with dementia. She also explained the most important aspect of care and the most recent advances of care for patients in this specific population. Zawar provided detail on the previous research that has revealed the knowledge gaps between epilepsy and dementia.
Reference
Zawar I. Seizures in dementia associated with worse clinical outcomes, higher mortality rates and shorter lifespan. Presented at: AES Annual Meeting; December 2-6, 2022; Nashville, TN, and virtual.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Solving the Transition Conundrum as More Children With Muscular Dystrophy Live to Adulthood
March 17th 2025Learning from examples like congenital heart disease and cystic fibrosis can help health systems and clinicians prepare to care for an influx of patients with neuromuscular diseases as they reach adulthood thanks to transformative therapy advances.
Read More